4//SEC Filing
LOWE CHRISTOPHER P. 4
Accession 0001209191-21-064924
CIK 0001662774other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 8:17 PM ET
Size
7.0 KB
Accession
0001209191-21-064924
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
LOWE CHRISTOPHER P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-11-16−30,000→ 103,294 totalExercise: $2.23Exp: 2028-11-27→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2021-11-16$2.23/sh+30,000$66,900→ 90,000 total
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.
Documents
Issuer
Cortexyme, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001376260
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 8:17 PM ET
- Size
- 7.0 KB